New hope for stomach bug: tegoprazan combo may beat antibiotic resistance
NCT ID NCT06382493
First seen Apr 29, 2026 · Last updated May 08, 2026 · Updated 2 times
Summary
This study compares two 10-day treatments for Helicobacter pylori infection, a stomach bug that can cause ulcers and cancer. Researchers want to see if a newer drug (tegoprazan) works better than standard proton pump inhibitors when combined with antibiotics. The trial will enroll 400 adults in South Korea, a region with high antibiotic resistance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, Gyeonggi-do, 463-707, South Korea
Contact
Conditions
Explore the condition pages connected to this study.